{"id":8251,"date":"2015-02-26T08:04:11","date_gmt":"2015-02-26T08:04:11","guid":{"rendered":"https:\/\/heliospectra.com\/blog\/mfn_news\/year-end-report-2014\/"},"modified":"2025-04-09T17:40:03","modified_gmt":"2025-04-09T17:40:03","slug":"year-end-report-2014","status":"publish","type":"mfn_news","link":"https:\/\/heliospectra.com\/blog\/mfn_news\/year-end-report-2014\/","title":{"rendered":"Year end report 2014"},"content":{"rendered":"
\n
July – December:
· Net turnover was KSEK 1,247 (289)
· Operating profit\/loss was KSEK -14,072 (-5,258)
· Profit\/loss after tax was, SEK -14,068 (-5,266) or SEK -1 (-662) per share
· Operating cash flow was KSEK -15,627 (-4,770)<\/p>\n
\n
<\/strong><\/div>\n
January – December <\/strong> Events after the period: <\/strong> CEO’s comments: <\/strong> During the latter part of 2014, we have commenced the launch of our new products LX60 and RX30 series based on the same technical platform in order to achieve economies of scale. In North America, Professor Bruce Bugbee has noted that we have one of the best products on the market and this has been further confirmed by initial orders from strategically important customers. The collaboration with international actors such as MIT Media Lab and the German Aerospace Centre DLR are indications of our innovative ability to develop world-leading technology.<\/p>\n Moving forward, we will focus on marketing and sales, primarily in the North American market, but also in the Europe. North America is expanding, in particular within the field of medicinal plants, although we have also noted an increasing demand from traditional greenhouses and new applications such as cultivation near to larger food stores.<\/p>\n We have built up a strong, competent team with international staff who are all passionate about their work. World-leading technology, a market with rapid growth, competent staff and strong main shareholders is a winning combination.<\/p>\n Staffan Hillberg, CEO Upcoming reporting dates<\/strong> For a full report see attached pdf.<\/em><\/p>\n Gothenburg 26 February 2015<\/p>\n <\/p>\n The board<\/p>\n <\/em><\/p>\n For further information, please contact <\/strong> The following documents can be retrieved from beQuoted <\/p>\n Heliospectra in brief <\/strong> <\/em><\/p>\n
· Net turnover was KSEK 3,110 (486)
· Operating profit\/loss was KSEK -32,901 (-17,141)
· Profit\/loss after tax was, SEK -33,670 (-17,117) or SEK -2 (-2,150) per share
· Operating cash flow was KSEK -32,668 (-9,656)<\/p>\n
· Heliospectra receives an order to the value of ca. SEK 1 million from an existing customer for the cultivation of medicinal plants.
· The company has secured loan financing to compensate for the negative cash flow.<\/p>\n
2014 has been an eventful year for Heliospectra. We have gained over 1,000 shareholders, many of whom actively follow the company’s growth after our listing in the summer. At the same time, we have implemented various initiatives to attract investors and strategic partners on the US market where Heliospectra is receiving great interest with its strong brand, top-ranking products, an expressed SaaS strategy as well as a focus on sustainable food production. The objective is to create a good foundation for our continued expansion.<\/p>\n
Heliospectra AB<\/p>\n
· Quarterly report Q1 30\/4\/2015
· Annual General Meeting 5\/6\/2015
· Half-year report January-June 31\/8\/2015
· Quarterly report July-September 26\/10\/2015
· Financial statement bulletin 2015 26\/02\/2015<\/p>\n
CEO Staffan Hillberg, +46 (0)708-365944, staffan@heliospectra.com<\/a>
Chairman Jan Tufvesson, +46 (0)706-442460, jan.tuf@telia.com<\/a>
CFO Håkan Bengtsson, +46 (0)705-558902, hakan.bengtsson@heliospectra.com<\/a><\/p>\n
Heliospectra Year end report 2014 (English).pdf<\/a>
Heliospectra Bokslutskommuniké 2014 (Swedish).pdf<\/a><\/p>\n
Heliospectra (publ – listed on Nasdaq OMX First North) was founded in 2006 and specializes in intelligent lighting technology for plant research and greenhouse cultivation. Heliospectra products are based on in-depth knowledge of plant physiology and photosynthesis together with a unique method of assimilating modern LED technology. After six years of development in Sweden, the company has now begun to expand on the international market. The company has amassed approximately MUSD 16 of equity and has received over 2.6 million dollars through academic scholarships. Heliospectra has also received numerous awards for its forward thinking technology. For further information, please refer to Heliospectra’s prospectus April\/May 2014, http:\/\/ir.heliospectra.com\/aktien\/prospekt\/<\/a>.<\/p>\n